Given Kindlin-2’s role as a coactivator of integrin activities and its interaction with TβRI, our study investigated the impact of inhibiting these interactions on downstream signaling of both Integrins and TβRI, and their role in TNBC tumor progression and metastasis. The gene discussed is FERMT2; the disease is neoplasm.